Literature DB >> 27193706

Antitumor effect of arabinogalactan and platinum complex.

A K Starkov1, T N Zamay2,3,4, A A Savchenko5,6, E V Ingevatkin5, N M Titova6, O S Kolovskaya5,7, N A Luzan6, P P Silkin6, S A Kuznetsova1,6.   

Abstract

The article presents the results of investigation of antitumor properties of platinum-arabinogalactan complex. We showed the ability of the complex to inhibit the growth of Ehrlich ascites tumor cells. It is found that the distribution of the platinum-arabinogalactan complex is not specific only for tumor cells in mice. The complex was found in all tissues and organs examined (ascites cells, embryonic cells, kidney, and liver). The mechanism of action of the arabinogalactan-platinum complex may be similar to cisplatin as the complex is able to accumulate in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27193706     DOI: 10.1134/S1607672916020046

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  4 in total

Review 1.  Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin.

Authors:  R S Go; A A Adjei
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

2.  Oral administration of arabinogalactan affects immune status and fecal microbial populations in dogs.

Authors:  Christine M Grieshop; Elizabeth A Flickinger; George C Fahey
Journal:  J Nutr       Date:  2002-03       Impact factor: 4.798

3.  Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats.

Authors:  Y Kaneo; T Ueno; T Tanaka; H Iwase; Y Yamaguchi; T Uemura
Journal:  Int J Pharm       Date:  2000-05-15       Impact factor: 5.875

4.  Arabinogalactan for hepatic drug delivery.

Authors:  E V Groman; P M Enriquez; C Jung; L Josephson
Journal:  Bioconjug Chem       Date:  1994 Nov-Dec       Impact factor: 4.774

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.